The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
had a large impact on global health, travel, and economy. Therefore, preventative and …

Large-scale vaccination campaigns have prevented countless hospitalizations and deaths
due to COVID-19. However, the emergence of SARS-CoV-2 variants that escape from …

Large-scale vaccination campaigns have prevented countless SARS-CoV-2 infections,
hospitalizations and deaths. However, the emergence of variants that escape from immunity …

One of the major breakthroughs to combat the current Coronavirus Disease 2019 (COVID-19)
pandemic has been the development of highly effective vaccines against the Severe Acute …

Patients diagnosed with coronavirus disease 2019 (COVID-19) become critically ill primarily
around the time of activation of the adaptive immune response. Here, we provide evidence …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing
to disrupt personal lives, global healthcare systems, and economies. Hence, there is an …

Background Emerging and future SARS-CoV-2 variants may jeopardize the effectiveness of
vaccination campaigns. Therefore, it is important to know how the different vaccines perform …

Emerging SARS-CoV-2 variants of concern (VOCs) pose a threat to human immunity induced
by natural infection and vaccination. We assessed the recognition of three VOCs (B.1.1.7, B…

Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …

Background Symptoms of post-acute sequelae of COVID-19 (PASC) may improve following
SARS-CoV-2 vaccination. However few prospective data that also explore the underlying …